Keyphrases
Muscle Protein Synthesis
100%
People with Obesity
76%
Insulin Resistance
72%
Older Adults
70%
Obesity
67%
Weight Loss
57%
Muscle Protein
56%
Fractional Synthesis Rate
55%
Adipose Tissue
46%
Muscle Mass
44%
Non-alcoholic Fatty Liver Disease (NAFLD)
42%
Postabsorptive State
41%
Insulin Sensitivity
41%
Postmenopausal Women
36%
Insulin
36%
Amino Acids
34%
Muscle Protein Turnover
33%
Protein Intake
32%
Older Women
31%
Metabolically Healthy Obesity
29%
Hyperinsulinemic-euglycemic Clamp
29%
Leucine
29%
Hyperinsulinemia
28%
Hyperaminoacidemia
28%
Skeletal muscle
27%
Low-density Lipoprotein
25%
N-3 Polyunsaturated Fatty Acids
25%
Testosterone
25%
Sexual Dimorphism
25%
Type 2 Diabetes Mellitus (T2DM)
24%
Plasma Glucose
23%
Metabolically Unhealthy Obesity
23%
Hepatic Fat
23%
Older Men
22%
Phenylalanine
21%
Omega-3 Fatty Acids
20%
Aging
20%
Middle-aged Women
19%
Liver
19%
Glucose Homeostasis
19%
Anabolic Response
19%
Dietary Weight Loss
18%
Physical Function
18%
Hyperglycemia
18%
Cardiometabolic Disease
18%
Low-density Lipoprotein Triglyceride
18%
Alanine Aminotransferase
17%
Gluconeogenesis
17%
Lifestyle Therapy
17%
Intensive Lifestyle
17%
Biochemistry, Genetics and Molecular Biology
Insulin Resistance
80%
Protein Biosynthesis
65%
Amino Acids
60%
Ingestion
48%
Skeletal Muscle
47%
Triglyceride
46%
Insulin Sensitivity
42%
Blood Plasma
36%
Leucine
33%
Metabolic Pathway
32%
Protein Degradation
31%
Insulin Release
25%
Adipocyte
25%
Sex Difference
25%
Glucose Homeostasis
21%
Lipogenesis
21%
Hyperglycemia
18%
Lipolysis
17%
Gluconeogenesis
17%
Alanine Transaminase
17%
Omega-3 Fatty Acid
17%
Postmenopause
17%
Progesterone
17%
Phenylalanine
17%
Estradiol
17%
Very Low-Density Lipoprotein
17%
Messenger RNA
15%
Premenopause
15%
Myostatin
13%
Mammalian Target of Rapamycin
12%
Omega 3 Fatty Acid
12%
Insulin Signaling
11%
Randomized Controlled Trial
11%
Protein Metabolism
11%
Impaired Glucose Tolerance
10%
Insulin Blood Level
10%
Polyunsaturated Fatty Acid
10%
Blood Lipids
9%
Oxygen Tissue Level
9%
Precursor
9%
Plasminogen Activator Inhibitor-1
8%
Mouse Mutant
8%
Small Hairpin RNA
8%
Fibrogenesis
8%
Glycemic Control
8%
Mitochondrial Membrane Transport Protein
8%
Tissue Oxygenation
8%
Adenine
8%
Small Molecule
8%
Insulin Clearance
8%
Medicine and Dentistry
Muscle Protein
63%
Adipose Tissue
62%
Protein Synthesis
53%
Insulin Sensitivity
40%
Maturity Onset Diabetes of the Young
31%
Skeletal Muscle
30%
Nonalcoholic Fatty Liver
29%
Triacylglycerol
25%
Insulin Resistance
23%
Postmenopause
22%
Obesity
20%
Supplementation
19%
Body Weight
17%
Sex Difference
17%
Glucose Homeostasis
17%
Omega-3 Fatty Acid
17%
Protein Degradation
16%
Radioactive Tracer
16%
Randomized Controlled Trial
14%
Insulin Signaling
13%
Body Mass Index
11%
Impaired Glucose Tolerance
11%
Protein Intake
11%
Fatty Acid
11%
Ceramide
11%
Non-Alcoholic Fatty Liver Disease
10%
Diabetes
10%
Glycemic Control
10%
Muscle Strength
10%
Diseases
10%
Overnutrition
10%
Energy Balance
10%
Protein Degradation
10%
Muscle Atrophy
9%
Aminoacidemia
9%
Hyperinsulinemia
9%
Protein Metabolism
9%
Homeostatic Model Assessment
9%
Caloric Restriction
9%
Fibrogenesis
8%
Immunology
8%
Fibroblast Growth Factor 19
8%
Exosome
8%
Fantasy
8%
Short Hairpin RNA
8%
Insulin Receptor
8%
Hand Grip
8%
Edema
8%
Metabolic Syndrome
8%
Hemoglobin A1c
8%
